Kpke E, Tung YC, Shaikh S, Alonso AC, Iqbal K, Grundke-Iqbal I
Safety and Follow-Up Sourcing, Oversight, Results, and Monitoring Medical screening: A responsible plan starts with goals, symptoms, health history, medications, risk factors, and treatment priorities
CMS, Medicare GLP-1 Bridge program page: Journal of Managed Care & Specialty Pharmacy, "Administrative costs of prior authorizations for glucagon-like peptide-1 agonists," 2026: Dusetzina, Stacie B
This calculator is for general educational and informational purposes only
Mounjaro (GLP-1 and GIP receptor agonist) is FDA-approved for the treatment of type 2 diabetes mellitus